The Cleveland Clinic is beginning a pilot program with a cloud service based on IBM’s Watson cognitive computing technology to aid its research into new cancer treatments.

IBM Chairman and CEO Ginni Rometty, speaking Wednesday at the 2014 Cleveland Clinic Medical Innovation Summit, said researchers at the clinic will use IBM’s Watson Genomics Analytics to advance the use of personalized medicine based on the patient’s genetic makeup.

With better analytics and cloud access to information, scientists and oncologists are hoping to be able to deliver personalized medicine to patients. By cutting through the daunting big data challenge of genomics, researchers can uncover new individualized cancer treatments based on patients’ specific DNA mutations.

To read this article in full or to leave a comment, please click here